Indacaterol

[Anonymous]

What happens now that the FDA only recommended the 75mcg dose. What does this do to the rest of the products that were to follow.

 

[Anonymous]

Do not worry about it. GSK here. We are already telling everyone how many people died in your studies.

 

[Anonymous]

Nice that our entire respiratory portfolio was based on 150. Sell your stock now and avoid the drop when this gets delayed.

 

[Anonymous]

That's okay, we weren't that excited to sell this BID Serevent me-too anyway.

 

[Anonymous]

my DM said that there may be more layoffs due to the delay with this. Is anyone else hearing this?

 

[Anonymous]

my DM said that there may be more layoffs due to the delay with this. Is anyone else hearing this?

Well duh, Gomer! What do you think?

 

[Anonymous]

We are dead in the water. There were gonna be 3 more drugs added onto the higher strength.

 

[Anonymous]

Another dud compound from the industry leaders in dud developement

Sincerely,

DUD MGMT TEAM LLC

 

[Anonymous]

Now that the FDA has delayed their decision, what does that mean for the future of the brand?

 

[Anonymous]

First of all it's not a BID Serevent.....it's actually QD.....huge difference but I expect your lack of knowledge in outcomes and compliance of BID vs QD henders you from understanding a lower dose is still going to be OK. You are probably spending all your time trying to find a way to sue instead doing your job of understanding the business.
Secondly indy was only a start.....still combo with a LAMA now in works or the LAMA mono therapy
At lastly you guys have no idea who is going to sale the product....be ready for a big surprise

 

[Anonymous]

Don't be fooled, this is one of the "promising" new drugs Novartis have in the "pipeline" that will "replace" Diovan when it goes generic to distract our attention until the next layoffs in October. Let's not be fooled there's nothing in the pipeline, nor aliskiren or anything else to make up for the Billions$$$ Diovan sells, the math is simple DIOVAN goes = LAYOFF! October is the date, mark your calendars.

 

[Anonymous]

First of all it's not a BID Serevent.....it's actually QD.....huge difference but I expect your lack of knowledge in outcomes and compliance of BID vs QD henders you from understanding a lower dose is still going to be OK. You are probably spending all your time trying to find a way to sue instead doing your job of understanding the business.
Secondly indy was only a start.....still combo with a LAMA now in works or the LAMA mono therapy
At lastly you guys have no idea who is going to sale the product....be ready for a big surprise

Sorry folks, but there is no real advantage to this product than those that are already on the market!

 

[Anonymous]

No real advantage? You are an idiot. If you would quit trying to find a way to sue and read the data that is in the public domain you will find this drugs beats foradil and tiotropium head to head. With that attitude even if the drug cured COPD, AIDS, and made your spouse better looking..you could not sell it.

Spend less time talking to your attorney and more time focusing on your job and you may start to be a little more successful in life. Diovan was a once in a lifetime blockbuster....get over it. You got fat and happy with it and without you are going to be exposed. If you are that miserable with your job LEAVE!!!!

And again.....don't worry about Indacaterol.....most of you wont be asked to sell it....you have no idea.